Archive

Webinar: How GLPs Enhance the Quality of Regulated and Non-Regulated Toxicology

October 18, 2016
This one-hour webinar, led by IIVS Director of Quality and Compliance, introduces some of the concepts of Good Laboratory Practices (GLPs) designed to promote study and data integrity within an in vitro toxicology framework. Applying these concepts within your own laboratory should aid in production of robust, repeatable studies. View Slides... 3T3 Neutral Red Uptake | Acute Respiratory Toxicity | Assessing Corneal Recovery | BCOP | Bronchial/Tracheal | CAMVA | Chronic Respiratory Toxicity | Ciliary Beat Frequency | Corneal Recovery Modeling | Corrositex

Next Generation Tobacco Products

August 24, 2016
IIVS has a long-standing history of working with various industries to help establish or utilize in vitro models for the prediction of risk and the assessment of products under development. With the Food and Drug Administration extending its authority to all tobacco products (including e-cigarettes, cigars, and hookah) the tobacco industry is faced with the task of assessing product safety for product development and regulatory submission. Further, the manufacture of tobacco products may entail risk to workers that come in... 3T3 Neutral Red Uptake | Acute Respiratory Toxicity | Bronchial/Tracheal | Chronic Respiratory Toxicity | Ciliary Beat Frequency | DPRA | Eye Irritation Test | Goblet Cell Hyperplasia | Inflammatory Biomarker Profiling | Inflammatory Cytokine Expression

Evaluation of a Reconstructed Human Oral Buccal Tissue Model as a Testing Platform for Determining the Oral Irritation Potential of Tobacco Products

December 1, 2014
Source: Assessment of In Vitro COPD Models for Tobacco Regulatory Science... Bronchial/Tracheal | Chronic Respiratory Toxicity | Oral - Gingival Screening | Oral Buccal | Tobacco